发明名称 COMBINATION CANCER TREATMENT
摘要 Described herein is TRAIL receptor targeting therapy in combination with metformin for treatment of cancer in humans. Using TRAIL receptor targeting therapy such as the TRAIL molecule, agonistic human monoclonal antibodies against TRAIL receptors, or peptides targeting TRAIL receptors in combination with metformin for the treatment of all types of cancer allows to obtain an optimum therapeutical effect at any time of the progression of the disease.
申请公布号 US2017049725(A9) 申请公布日期 2017.02.23
申请号 US201514706086 申请日期 2015.05.07
申请人 WISCONSIN ALUMNI RESEARCH FOUNDATION 发明人 Cryns Vincent Leonard;Malin Dmitry;Strekalova Elena
分类号 A61K31/155;A61K39/395;A61K38/17 主分类号 A61K31/155
代理机构 代理人
主权项 1. A method of treating cancer in a human individual in need of treatment for cancer, comprising co-administering metformin and a TRAIL receptor agonist, wherein the metformin is administered in an effective amount to sensitize cancer cells to the TRAIL receptor agonist.
地址 Madison WI US